Why Is MINIMED GROUP INC (MMED) Stock Down Today?

MiniMed Group Inc (Nasdaq: MMED) fell 3.21% to $19.30 in early trading on August 25, 2026. The decline came after the stock opened at $19.95 and quickly moved lower, reaching a session low of $19.29. The move follows a broader trend of volatility in the healthcare sector and a recent earnings call that may have raised concerns among investors.

What Happened

MiniMed announced it will participate in fireside chats at upcoming investor conferences, a move typically intended to boost visibility and investor confidence. However, the stock opened near its 52-week high before quickly reversing course. The decline may reflect broader market skepticism, as the company remains unprofitable with a trailing twelve-month (TTM) net margin of -10.7% and a TTM earnings per share (EPS) of -1.30. The session also occurred on the same day that the stock printed 14 fresh 52-week lows, indicating continued pressure from sellers.

MiniMed’s recent Q4 2026 earnings call, which took place earlier in the week, may have contributed to the sentiment. While the company reported a TTM revenue increase of 14.3%, the earnings call transcript suggests that investors may have been left with unresolved questions about the path to profitability. Additionally, Wells Fargo recently lowered its price target for MiniMed to $22, maintaining an Overweight rating, which could signal a shift in institutional expectations.

What The Data Shows

The stock is trading near the lower end of its 52-week range of $10.65 to $20.88. Intraday volume stands at 0.1 million shares, which is 0.1 times the 3-month daily average. The session low of $19.29 came at 10:45 AM ET, after the stock opened at its 52-week high. With a market capitalization of $5.7 billion, the stock’s decline reflects ongoing uncertainty about its ability to turn a profit despite growing revenue.

What To Watch

Investors will need to wait until June 3, 2026, for the next earnings report, which could provide more clarity on the company’s financial trajectory. Coverage of the stock remains limited, with only one story published in the last 36 hours.